In this model, intratumoral Tregs directly interacted with tumor associated CD11c+ dendritic cells (DCs) and reduced their expression of costimulatory molecules necessary for CD8+ T cell activation such as CD40, CD80 and CD86 (61). The gene discussed is ITGAX; the disease is neoplasm.